Dafydd Milton of Thermo Fisher Scientific, Runcorn, Cheshire, UK talks about the analytical challenges facing the pharmaceutical industry and developments made to overcome them.
Janet Kelsey, Editor of The Column spoke to Dafydd Milton of Thermo Fisher Scientific, Runcorn, Cheshire, UK about the analytical challenges facing the pharmaceutical industry and what developments have been made to overcome them.
Monitoring 5-Fluorouracil Levels in Dried Blood Spots with UHPLC-MS/MS
May 3rd 2024Researchers have utilized ultra-high performance liquid chromatography-tandem mass spectrometry (UH PLC-MS/MS) to monitor 5-Fluorouracil, a medication used to treat various cancers, in dried blood spots. This process offers a simpler, more efficient method than those in place involving the monitoring of plasma.
Metabolomics Meets Machine Learning: The Future of Nature-Inspired Drug Discovery
March 29th 2024Researchers at Enveda Biosciences are transforming nature into new medicines with their artificial intelligence (AI)-enabled industrial-scale drug discovery platform incorporating tandem mass spectrometry (MS/MS).
Element Launches New Pharmaceutical Testing Service
March 29th 2024Element Materials Technology introduced its Rapid Response Pharmaceutical Testing Service, providing expedited testing and focusing on various requirements including active ingredients and final drug products, extractables and leachables, degradation production, and elemental impurities.